FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 9, 2015, Pages 1867-1875

  Xiong, Xiao Qing ^a   Chen, Dan ^a   Sun, Hai Jian ^a   Ding, Lei ^a   Wang, Jue Jin ^a   Chen, Qi ^a   Li, Yue Hua ^a   Zhou, Ye Bo ^a   Han, Ying ^a   Zhang, Feng ^a   Gao, Xing Ya ^a   Kang, Yu Ming ^b   Zhu, Guo Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Insulin resistance; Irisin; Lipolysis; Metabolism; Obesity

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; FIBRONECTIN; FIBRONECTIN TYPE III DOMAIN CONTAINING 5; HORMONE SENSITIVE LIPASE; IRISIN; LENTIVIRUS VECTOR; MESSENGER RNA; NORADRENALIN; PERILIPIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LENTIVIRINAE; LIPID DIET; LIPID METABOLISM; LIPOLYSIS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

LENTIVIRUS; MUS;

EID: 84933565159     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.06.017     Document Type: Article

References (37)

1. Bostrom P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C., Rasbach K.A., Bostrom E.A., Choi J.H., Long J.Z., Kajimura S., Zingaretti M.C., Vind B.F., Tu H., Cinti S., Hojlund K., Gygi S.P., Spiegelman B.M. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
2. Park K.H., Zaichenko L., Peter P., Davis C.R., Crowell J.A., Mantzoros C.S. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism 2014, 63:233-241.
3. Zhang H.J., Zhang X.F., Ma Z.M., Pan L.L., Chen Z., Han H.W., Han C.K., Zhuang X.J., Lu Y., Li X.J., Yang S.Y., Li X.Y. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J. Hepatol. 2013, 59:557-562.
4. Huh J.Y., Panagiotou G., Mougios V., Brinkoetter M., Vamvini M.T., Schneider B.E., Mantzoros C.S. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012, 61:1725-1738.
5. Enerback S. Adipose tissue metabolism in 2012: adipose tissue plasticity and new therapeutic targets. Nat. Rev. Endocrinol. 2013, 9:69-70.
6. Algire C., Medrikova D., Herzig S. White and brown adipose stem cells: from signaling to clinical implications. Biochim. Biophys. Acta 2013, 1831:896-904.
7. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., Vasan R.S., Murabito J.M., Meigs J.B., Cupples L.A., D'Agostino R.B., O'Donnell C.J. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
8. Roca-Rivada A., Castelao C., Senin L.L., Landrove M.O., Baltar J., Belen C.A., Seoane L.M., Casanueva F.F., Pardo M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013, 8:e60563.
9. An Z., Wang H., Song P., Zhang M., Geng X., Zou M.H. Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress. J. Biol. Chem. 2007, 282:26793-26801.
10. Tanis R.M., Piroli G.G., Day S.D., Frizzell N. The effect of glucose concentration and sodium phenylbutyrate treatment on mitochondrial bioenergetics and ER stress in 3T3-L1 adipocytes. Biochim. Biophys. Acta 2015, 1853:213-221.
11. Gao M., Zhang C., Ma Y., Bu L., Yan L., Liu D. Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance. Mol. Ther. 2013, 21:1852-1861.
12. Rousso-Noori L., Knobler H., Levy-Apter E., Kuperman Y., Neufeld-Cohen A., Keshet Y., Akepati V.R., Klinghoffer R.A., Chen A., Elson A. Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner. Cell Metab. 2011, 13:562-572.
13. Miyamoto-Mikami E., Sato K., Kurihara T., Hasegawa N., Fujie S., Fujita S., Sanada K., Hamaoka T., Tabata I., Iemitsu M. Endurance training-induced increase in circulating irisin levels is associated with reduction of abdominal visceral fat in middle-aged and older adults. PLoS One 2015, 10:e0120354.
14. Humphreys M.H. The brain splits obesity and hypertension. Nat. Med. 2011, 17:782-783.
15. Xiong X.Q., Chen W.W., Zhu G.Q. Adipose afferent reflex: sympathetic activation and obesity hypertension. Acta Physiol. (Oxf.) 2014, 210:468-478.
16. Xiong X.Q., Chen W.W., Han Y., Zhou Y.B., Zhang F., Gao X.Y., Zhu G.Q. Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension 2012, 60:1280-1286.
17. Harms M., Seale P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 2013, 19:1252-1263.
18. Cypess A.M., White A.P., Vernochet C., Schulz T.J., Xue R., Sass C.A., Huang T.L., Roberts-Toler C., Weiner L.S., Sze C., Chacko A.T., Deschamps L.N., Herder L.M., Truchan N., Glasgow A.L., Holman A.R., Gavrila A., Hasselgren P.O., Mori M.A., Molla M., Tseng Y.H. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 2013, 19:635-639.
19. Lee P., Linderman J.D., Smith S., Brychta R.J., Wang J., Idelson C., Perron R.M., Werner C.D., Phan G.Q., Kammula U.S., Kebebew E., Pacak K., Chen K.Y., Celi F.S. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014, 19:302-309.
20. Smith C.E., Ordovas J.M. Update on perilipin polymorphisms and obesity. Nutr. Rev. 2012, 70:611-621.
21. Saha P.K., Kojima H., Martinez-Botas J., Sunehag A.L., Chan L. Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J. Biol. Chem. 2004, 279:35150-35158.
22. Bartness T.J., Liu Y., Shrestha Y.B., Ryu V. Neural innervation of white adipose tissue and the control of lipolysis. Front. Neuroendocrinol. 2014, 35:473-493.
23. Souza S.C., de Vargas L.M., Yamamoto M.T., Lien P., Franciosa M.D., Moss L.G., Greenberg A.S. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 1998, 273:24665-24669.
24. Souza S.C., Muliro K.V., Liscum L., Lien P., Yamamoto M.T., Schaffer J.E., Dallal G.E., Wang X., Kraemer F.B., Obin M., Greenberg A.S. Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system. J. Biol. Chem. 2002, 277:8267-8272.
25. Watt M.J., Holmes A.G., Pinnamaneni S.K., Garnham A.P., Steinberg G.R., Kemp B.E., Febbraio M.A. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E500-E508.
26. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010, 11:11-18.
27. Hamdy O., Porramatikul S., Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr. Diabetes Rev. 2006, 2:367-373.
28. Tulloch-Reid M.K., Hanson R.L., Sebring N.G., Reynolds J.C., Premkumar A., Genovese D.J., Sumner A.E. Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in African Americans. Obes. Res. 2004, 12:1352-1359.
29. Beranger G.E., Karbiener M., Barquissau V., Pisani D.F., Scheideler M., Langin D., Amri E.Z. In vitro brown and "brite"/"beige" adipogenesis: human cellular models and molecular aspects. Biochim. Biophys. Acta 2013, 1831:905-914.
30. Bonet M.L., Oliver P., Palou A. Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim. Biophys. Acta 2013, 1831:969-985.
31. Elsen M., Raschke S., Eckel J. Browning of white fat: does irisin play a role in humans?. J. Endocrinol. 2014, 222:R25-R38.
32. Kirwan J.P., del Aguila L.F. Insulin signalling, exercise and cellular integrity. Biochem. Soc. Trans. 2003, 31:1281-1285.
33. Lee W.J., Almulaifi A. Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence. J. Biomed. Res. 2015, 29:98-104.
34. Ganguly S., Tan H.C., Lee P.C., Tham K.W. Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective. J. Biomed. Res. 2015, 29:105-111.
35. Farias M.M., Cuevas A.M., Rodriguez F. Set-point theory and obesity. Metab. Syndr. Relat. Disord. 2011, 9:85-89.
36. Keesey R.E., Hirvonen M.D. Body weight set-points: determination and adjustment. J. Nutr. 1997, 127:1875S-1883S.
37. Muller M.J., Bosy-Westphal A., Heymsfield S.B. Is there evidence for a set point that regulates human body weight?, F1000. Med. Rep. 2010, 2:59.